Vytorin is a relatively new drug used to treat hypercholesterolemia, and it actually contains two active, efficacious ingredients. Vytorin contains a statin drug that inhibits a crucial enzyme in cholesterol biosynthesis, but it also contains a compound that inhibits the intestinal absorption of cholesterol from the diet. Which of the following is an accurate assessment of whether this drug can or cannot be used to treat familial hypercholesterolemia (FH)?